Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 31.42% is 19% above its 5-year average of 26.40%, near the high end of its 5-year range (17.68%–32.39%).
As of the fiscal period ended Sunday, June 28, 2026. 1.75% above its 12-month average of 30.88%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
31.42%
DEBT TO ASSETS RATIO AVG TTM
30.88%
DEBT TO ASSETS RATIO AVG 3Y
30.57%
DEBT TO ASSETS RATIO AVG 5Y
26.40%
DEBT TO ASSETS RATIO AVG 10Y
26.98%
DEBT TO ASSETS RATIO AVG 15Y
25.21%
DEBT TO ASSETS RATIO AVG 20Y
24.09%
CURRENT VS TTM AVG
+1.75%
CURRENT VS 3Y AVG
+2.78%
CURRENT VS 5Y AVG
+19.02%
CURRENT VS 10Y AVG
+16.45%
CURRENT VS 15Y AVG
+24.63%
CURRENT VS 20Y AVG
+30.43%
SECTOR MEDIAN · HEALTHCARE
0.28%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+11121.19%
vs the sector median at left
Pfizer Inc.
Market Cap
$158.39B
Debt to Assets Ratio
31.42%
TTM Avg
30.88%
3Y Avg
30.57%
5Y Avg
26.40%
Market Cap
$182.06B
Debt to Assets Ratio
0.53%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$134.24B
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$132.14B
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$123.70B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pfizer Inc. (PFE) | $158.39B | 31.42% | 30.88% | 30.57% | 26.40% |
| Danaher Corporation (DHR)vs › | $144.25B | 0.29% | N/A | N/A | N/A |
| Gilead Sciences, Inc. (GILD)vs › | $182.06B | 0.53% | N/A | N/A | N/A |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.24B | 0.07% | N/A | N/A | N/A |
| Abbott Laboratories (ABT)vs › | $182.59B | 0.30% | N/A | N/A | N/A |
| Bristol-Myers Squibb Company (BMY)vs › | $132.14B | 0.49% | N/A | N/A | N/A |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.70B | 0.00% | N/A | N/A | N/A |
| CVS Health Corp. (CVS)vs › | $122.58B | 0.30% | N/A | N/A | N/A |
| Medtronic plc (MDT)vs › | $118.26B | 0.00% | N/A | N/A | N/A |
| Novo Nordisk A/S (NVO)vs › | $200.54B | 0.24% | N/A | N/A | N/A |
Debt/Assets
31.4%
Debt/Equity
0.74
Current Ratio
1.27
Interest Coverage
5.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-28 | 31.42% |
| 2026-03-29 | 31.04% |
| 2025-12-31 | 32.39% |
| 2025-09-28 | 29.57% |
| 2025-06-29 | 29.98% |
| 2025-03-29 | 29.46% |
| 2024-12-31 | 29.83% |
| 2024-09-29 | 30.35% |
| 2024-06-30 | 31.77% |
| 2024-03-31 | 31.08% |
| 2023-12-31 | 31.28% |
| 2023-10-01 | 29.58% |
| 2023-07-02 | 29.68% |
| 2023-04-02 | 17.85% |
| 2022-12-31 | 17.68% |
| 2022-10-02 | 18.26% |
| 2022-07-03 | 20.04% |
| 2022-04-03 | 19.07% |
| 2021-12-31 | 20.39% |
| 2021-10-03 | 21.43% |
| 2021-07-04 | 22.21% |
| 2021-04-04 | 24.05% |
| 2020-12-31 | 24.82% |
| 2020-09-27 | 34.38% |
| 2020-06-28 | 35.75% |
| 2020-03-29 | 31.43% |
| 2019-12-31 | 30.35% |
| 2019-09-29 | 30.89% |
| 2019-06-30 | 29.88% |
| 2019-03-31 | 29.05% |
| 2018-12-31 | 26.19% |
| 2018-09-30 | 28.86% |
| 2018-07-01 | 24.56% |
| 2018-04-01 | 24.80% |
| 2017-12-31 | 24.80% |
| 2017-10-01 | 25.53% |
| 2017-07-02 | 25.93% |
| 2017-04-02 | 26.07% |
| 2016-12-31 | 23.93% |
| 2016-10-02 | 24.70% |
| 2016-07-03 | 25.89% |
| 2016-04-03 | 24.16% |
| 2015-12-31 | 23.23% |
| 2015-09-27 | 22.76% |
| 2015-06-28 | 21.83% |
| 2015-03-29 | 22.36% |
| 2014-12-31 | 21.67% |
| 2014-09-28 | 21.62% |
| 2014-06-29 | 21.92% |
| 2014-03-30 | 21.52% |
| 2013-12-31 | 21.20% |
| 2013-09-29 | 20.82% |
| 2013-06-30 | 20.49% |
| 2013-03-31 | 21.55% |
| 2012-12-31 | 20.16% |
| 2012-09-30 | 21.28% |
| 2012-07-01 | 21.10% |
| 2012-04-01 | 21.04% |
| 2011-12-31 | 20.71% |
| 2011-10-02 | 20.92% |
| 2011-07-03 | 21.29% |
| 2011-04-03 | 21.24% |
| 2010-12-31 | 22.58% |
| 2010-10-03 | 23.07% |
| 2010-07-04 | 22.65% |
| 2010-04-04 | 23.60% |
| 2009-12-31 | 22.85% |
| 2009-09-27 | 32.70% |
| 2009-06-28 | 33.40% |
| 2009-03-29 | 28.83% |
| 2008-12-31 | 15.55% |
| 2008-09-28 | 14.18% |
| 2008-06-29 | 14.33% |
| 2008-03-30 | 14.38% |
| 2007-12-31 | 11.40% |
| 2007-09-30 | 7.97% |
| 2007-07-01 | 7.44% |
| 2007-04-01 | 6.71% |
| 2006-12-31 | 6.95% |
| 2006-10-01 | 7.43% |
| 2006-07-02 | 8.27% |
| 2006-04-02 | 10.24% |
| 2005-12-31 | 15.26% |
| 2005-10-02 | 11.00% |
| 2005-07-03 | 11.38% |
| 2005-04-03 | 16.13% |
| 2004-12-31 | 14.99% |
| 2004-09-26 | 15.39% |
| 2004-06-27 | 15.81% |
| 2004-03-28 | 14.59% |
| 2003-12-31 | 12.48% |
| 2003-09-28 | 13.19% |
| 2003-06-29 | 12.01% |
| 2003-03-30 | 24.52% |
| 2002-12-31 | 25.47% |
| 2002-09-29 | 30.77% |
